CLARITY IN
CANCER CARE

End-to-End Quality Assurance Device

Meet our first product: Qualyscan. Our all-in-one solution for mastering quality control in Proton Therapy Technology.

About us

Next generation imaging technology bringing nuclear and precision medicine to the next level

Terapet SA, is a Geneva-based CERN MedTech spin-off, that has developed an innovative platform technology for imaging in nuclear medicine, bringing proton therapy and nuclear imaging to the next level.

Mission and Vision of our company

Next Generation Imaging Technology

Terapet’s mission is to develop an innovative platform technology with integrated solutions for imaging in nuclear medicine, bringing proton therapy, nuclear imaging and precision medicine to the next level.

Terapet envisions that its Qualyscan™ and Claryscan™ will enable QUALITY and CLARITY in every patient’s diagnostic and treatment, making them the first choice for radiotherapy and precision medicine in the near future.

We are collaborating with
We are supported by
Our Awards